Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000893:Anti-Inflammatory Agents; D002738:Chloroquine / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D004247:DNA / Q000502:physiology; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects / Q000494:pharmacology; D007166:Immunosuppressive Agents; D008297:Male; D008543:Melanins / Q000502:physiology; D009468:Neuromuscular Diseases / Q000139:chemically induced; D011164:Porphyrias / Q000188:drug therapy; D011247:Pregnancy; D011796:Quinacrine / Q000378:metabolism / Q000494:pharmacology*; D012867:Skin / Q000187:drug effects; D013473:Sunscreening Agents
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D008543:Melanins; D013473:Sunscreening Agents; D006886:Hydroxychloroquine; D002738:Chloroquine; D004247:DNA; D011796:Quinacrine